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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comBackground: Radiation exposure is associated with increased risk of malignancies and
cataract formation. Recent case series of predominantly left sided brain malignancies in
interventional cardiologists suggest an increased risk with long term exposure to
occupational radiation. These data suggest that further measures to protect healthcare
workers are needed. We aimed to evaluate the efﬁcacy of two novel shields in reducing
interventional cardiologists’ radiation exposure during angiographic procedures.
Methods: We conducted a prospective, randomized, controlled clinical trial with
enrollment of 230 patients undergoing coronary angiography or percutaneous coronary
intervention from November 2013 to May 2014. Patients were randomized to have their
procedure performedwith orwithout placement of a pelvic lead shield designed for either
radial or femoral access, and designed to reduce radiation scatter. During all procedures,
an interventional cardiologist was ﬁtted with a novel, paper thin, non-lead surgical cap
(No Brainer, RADPAD, weight 53 grams) to protect the brain from radiation exposure.
The co-primary outcomes for the lead shield comparison was i) the difference between
both groups in total operator radiation dose (mSv) at the left chest level and ii) the dif-
ference between groups in operator dose divided by Air Kerma (mSv/mGy). For the cap
comparison, the primary outcome was the difference between total radiation dose (mSv)
as measured by two dosimeters at left temporal region of the head of the interventional
cardiologist (one on the outside of the cap and the other one on the inside of it). Radiation
dose was measured using Unfors Educational Direct Dosimeters (EDD-30).
Results: The full results of the study will be available at time of presentation.
Conclusions: The RADIATION PROTECT study will help determine the efﬁcacy of
a novel lead shield and a novel non-lead surgical cap for reducing operator radiation
exposure during coronary angiography or intervention.
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Background: During interventional cardiology procedures patient and staff are
exposed to X-ray radiation. Minimizing radiation dose is a crucial part of quality care.
This study quantiﬁes the radiation dose reduction for patient and staff enabled by a
novel X-ray imaging technology using advanced real-time image noise reduction
algorithms and an optimized acquisition chain (AlluraClarity, Philips Healthcare, The
Netherlands). First results are reported.
Methods: Between March-May 2014, 48 patients referred for coronary angiography
and angioplasty were prospectively scheduled and randomized for room A (FD10
monoplane system with state of the art image processing and reference acquisition
chain) or room B (FD2010 biplane system with the novel imaging technology) in a
1:2 ratio. Patients’ demographics and procedure characteristics were recorded; expo-
sure parameters from all planes were logged via DICOM SR. Scatter dose is quantiﬁed
by a dosimeter placed on the C-arc, at a ﬁxed position, not affected by any shielding
device. Occupational dose is quantiﬁed by dosimeters placed on the torso and leg of
physicians and logged via DICOM SR (DoseAware Xtend, Philips Healthcare, Best,
The Netherlands).
Results: Demographic data, exposure parameters and occupational doses are sum-
marized in Table 1, showing comparable patient demographics and procedure
complexity for room A and B. DAP values for ﬂuoroscopy and exposure decreased
with 33% and 75%, respectively. Scatter dose decreased with 67% in room B for the
C-arc dosimeter and 53% for the physician leg. However, physician torso dose (less
than 35% of leg dose) did not differ signiﬁcantly. This needs to be further investigated.Table 1. Patient demographic data and exposure parameters
Room A (n¼17) Room B (n¼31) p-value
No. of males / females 15 / 2 16 / 15 0.11
Age, y 66 (58-78) 64 (59-69) 0.706
BMI, kg/m2 27 (24-31) 26 (23-31) 0.612
Only CA / CA+PCI 16 / 1 25 / 6 0.206
DAP total, Gycm2 64.7 (48.7-90.6) 20.4 (13.5-34.7) <0.001
DAP ﬂuoro, Gycm2 7.02 (3.56-11.2) 4.70 (3.02-14.3) 0.348
DAP exposure, Gycm2 56.5 (45.3-75.1) 14.2 (9.81-22.8) <0.001
No. of exposure images 858 (709-916) 1070 (767-1311) 0.013
No. of exposure runs 11 (10-12) 12 (10-13) 0.206
Fluoroscopy time, s 116 (74-195) 172 (114-301) 0.062
CMV, mL 112 (104-130) 119 (99-138) 0.746
Reference scatter dose, mSv 728 (506-875) 241 (118-426) <0.001
Physician leg dose, mSv 226 (137-343) 106 (51.0-151) 0.004
Physician torso dose, mSv 36.2 (13.4-129) 51.5 (26.0-74.6) 0.525
BMI: body mass index; DAP: dose area product; CMV: contrast medium volume. Values
represent the median (Q1-Q3).Conclusions: The novel X-ray imaging technology resulted in a signiﬁcant and
substantial patient and occupational dose reduction, without affecting patient and
procedure characteristics.B44 JACC Vol 64/11/Suppl BTCT-147
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Background: A novel X-ray imaging technology (AlluraClarity, Philips Healthcare,
Best, The Netherlands) enables patient radiation dose reduction by a combination of
advanced image noise reduction algorithms with state-of-the-art hardware and an
anatomy-speciﬁc optimized full acquisition chain. The main purpose of this analysis is
to quantify patient radiation exposure during coronary angiography and intervention in
real life using the novel ClarityIQ technology.
Methods: Retrospective data was collected for the entire cohort of patients admitted
for coronary interventions with the Allura Xper or AlluraClarity in our institution
during the period November 2013 to March 2014. Patients were allocated to each
equipment according to availability, unrelated to patient’s characteristics and condi-
tions. The primary endpoint was overall procedural patient dose, expressed in air
kerma and dose area product (DAP).
Results: The analysis comprised 1215 consecutive patients undergoing coronary
diagnostic and therapeutic interventions, 532 (44 %) performed with AlluraClarity and
683 (56 %) with the Allura Xper. Clinical characteristics were similar among both
groups, including BMI and weight. Air Kerma in the Allura Xper and AlluraClarity
group were 930 mGy (IQR 517-1686) and 591 mGy (IQR 319-1173), respectively
(37% reduction with Clarity, 95%CI 32 to 42%; p < 0,0001). DAP in the Xper and
Clarity group were 98959 mGy/cm2 (IQR 52944-174757) and 59042 Gy/cm2 (IQR
32382.5-106784.5), respectively (41% reduction with Clarity, 95%CI 36 to 46%;
p < 0,0001). Same radiation exposure reduction with Kerma and DAP were detected
adjusting by radiation time. No signiﬁcant differences were detected on radiation time
(8.4 vs 9.2 minutes; p ¼ 0,58) or contrast used adjusted by radiation time (13,6 vs
13,20 mL/min; p ¼ 0,32) in the Xper and Clarity group, respectively.
Conclusions: A profound reduction in procedural patient radiation exposure was
measured by comparing the AlluraClarity with the Allura Xper equipment for patients
undergoing coronary interventions with no impact in the radiation time and contrast
use. Reduction of patient and operator radiation exposure is one of the most important
challenges of modern cathlabs.
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Background: The safety and feasibility of robotic-assisted percutaneous coronary
intervention (PCI) with the CorPath 200 (Corindus, Boston, MA) in simple coronary
lesions has been demonstrated.
Methods: This is a single center registry report of all consecutive robotic assisted PCI
procedures performed with the CorPath 200.
Results: We enrolled 19 patients (mean age 68;74% male) and demonstrate that 52%
of the cases performed were for type C lesions, with 16 of 19 cases performed entirely
robotically or with minimal manual manipulation. Procedural and clinical success for
the series and contrast/ﬂuoroscopy time used for the group are reported.
Conclusions: The CorPath 200 robotic system can be used to treat complex coronary
lesions including type C lesions, saphenous vein graft lesions, chronic total occlusions,
multilesion ormultivessel disease, andwith arterial access obtainedvia the radial approach.j September 13–17, 2014 j TCT Abstracts/Cath Lab of the Future
